Company: GANX
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001558370-25-007747
Chunk: 6

Company: Gain Therapeutics, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part II, Item 1
Chunk 6
---
Item 1. Legal Proceedings.

As previously disclosed, the Company and two members of its board of directors were named as defendants in a lawsuit filed in the Circuit Court of Maryland for Montgomery County by Matthias Alder, the Company’s former Chief Executive Officer. Following mediation, on May 13, 2025 the parties reached an agreement in principle to settle the case and subsequently executed a settlement agreement which, if not revoked during a 7-day revocation period, will become effective on May 20, 2025 and require dismissal of the lawsuit.